Ethypharm for Business

Our Corporate Development activities are fully focused on the reinforcement of our position along three axes:

• Commercial presence in Europe : any type of business opportunity (assets, in-licensing or company acquisition) which will reinforce our position in our existing markets or allow us to expand our presence in Europe will be given consideration.
• Central nervous system and hospital injectables : we are looking for already marketed or late-stage R&D branded prescription medicines to complement our existing portfolio of products in these two major areas.
• Rare diseases in China : our longstanding affiliate, which has a deep knowledge of the local fast-changing market, and is a partner of choice for international companies wishing to register and commercialise their rare disease medicines in China.

Ethypharm’s dedicated Corporate Development team is composed of professional individuals who have a proven track record in developing business partnerships.  Acting both as scouts and business process managers, each member of the team can rely on the full support of our internal experts to conduct an initial assessment and due diligence in a timely manner.

Our robust internal process also guarantees that our shareholders are fully aligned from the start and ready to support the financing of the deal if needed.